John Francisco Guerrero, FNP

John Guerrero practices at Dacareinc in El Centro, California.

John Guerrero's NPI, 1154801280, was assigned on August 17, 2018. John Guerrero holds California license 95011556.

John Guerrero's primary practice is Dacareinc, at 757 W Main St, El Centro, CA 92243 in Imperial County. The practice phone is (760) 337-8393.

John Guerrero's primary practice is Dacareinc in El Centro, California. John Guerrero is also affiliated with El Centro Regional Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links John Guerrero to 1 more hospital, 4 home health agencies, 4 medical groups, 3 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Guerrero practices, 10 sites in all. Vendor and product names are available with a free account.

Family is John Guerrero's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Dmand AI has John Guerrero's licenses on file in 2 states: California and Arizona.

Dmand AI lists acute gastroduodenitis, acute skin infection, alcohol use disorders, alzheimer's disease, anxiety, arthritis, asthma and bladder disease among the conditions John Guerrero treats.

CMS data shows 6,843 Medicare services from John Guerrero across 29 procedure codes in 2024, for 486 Medicare patients. Medicare paid $373,015 for them.

CMS counts 486 Medicare patients who saw John Guerrero in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 81% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Guerrero's median patient age at 70, with 54% women.

In 2024, John Guerrero wrote 7,918 Medicare Part D claims for 452 patients. 85% of them were for generic drugs. CMS names the drug for 7,201 of them, across 147 drugs with 11 or more claims each, at $621,549 in total drug cost.

John Guerrero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists John Guerrero as offering telehealth.

CMS Open Payments shows 58 general payments to John Guerrero from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $405.